Ryan Lynch - Net Worth and Insider Trading
Ryan Lynch Net Worth
The estimated net worth of Ryan Lynch is at least $290,604 dollars as of 2026-08-11. Ryan Lynch is the See Remarks of Crescent Biopharma Inc and owns about 13,871 shares of Crescent Biopharma Inc (CBIO) stock worth over $240,384. Ryan Lynch is also the PFO, PAO of Concert Pharmaceuticals Inc and owns about 6,000 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $50,220. Details can be seen in Ryan Lynch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ryan Lynch has not made any transactions after 2026-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ryan Lynch
Ryan Lynch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ryan Lynch owns 2 companies in total, including Concert Pharmaceuticals Inc (CNCE) , and Crescent Biopharma Inc (CBIO) .
Click here to see the complete history of Ryan Lynch’s form 4 insider trades.
Insider Ownership Summary of Ryan Lynch
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CNCE | Concert Pharmaceuticals Inc | 2017-09-14 | PFO & PAO |
| CBIO | Crescent Biopharma Inc | 2026-06-22 | See Remarks |
Ryan Lynch Latest Holdings Summary
Ryan Lynch currently owns a total of 2 stocks. Among these stocks, Ryan Lynch owns 13,871 shares of Crescent Biopharma Inc (CBIO) as of June 22, 2026, with a value of $240,384 and a weighting of 82.72%. Ryan Lynch also owns 6,000 shares of Concert Pharmaceuticals Inc (CNCE) as of September 14, 2017, with a value of $50,220 and a weighting of 17.28%.
Latest Holdings of Ryan Lynch
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBIO | Crescent Biopharma Inc | 2026-06-22 | 13,871 | 17.33 | 240,384 |
| CNCE | Concert Pharmaceuticals Inc | 2017-09-14 | 6,000 | 8.37 | 50,220 |
Holding Weightings of Ryan Lynch
Ryan Lynch Form 4 Trading Tracker
According to the SEC Form 4 filings, Ryan Lynch has made a total of 1 transactions in Crescent Biopharma Inc (CBIO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Crescent Biopharma Inc is the sale of 465 shares on June 22, 2026, which brought Ryan Lynch around $8,365.
According to the SEC Form 4 filings, Ryan Lynch has made a total of 0 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 3,500 shares on September 14, 2017, which brought Ryan Lynch around $50,785.
Insider Trading History of Ryan Lynch
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Ryan Lynch Trading Performance
Ryan Lynch Ownership Network
Ownership Network List of Ryan Lynch
Ownership Network Relation of Ryan Lynch
Ryan Lynch Owned Company Details
What does Concert Pharmaceuticals Inc do?
Who are the key executives at Concert Pharmaceuticals Inc?
Ryan Lynch is the PFO & PAO of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Legal Officer Jeffrey A Munsie , Chief Development Officer James V Cassella , and CFO & PFO Marc A. Becker .
Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Concert Pharmaceuticals Inc Insider Transactions
Ryan Lynch Mailing Address
Above is the net worth, insider trading, and ownership report for Ryan Lynch. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ryan Lynch's mailing address is: Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
